natgillin/translations-raw huggingface dataset:
ker zdaj v EU obstajajo velike in nesprejemljive razlike v kakovosti preventivnih pregledov za rakava obolenja ter zgodnjega odkrivanja in spremljanja, zlasti kar zadeva uporabljene diagnostične postopke in vključevanje teh postopkov v zdravstveno politiko držav članic; ker preventivni pregledi olajšajo zgodnje diagnosticiranje, kar prispeva k stroškovno učinkovitemu in merljivemu zmanjšanju števila primerov rakavih obolenj,
whereas there are currently considerable, and unacceptable, qualitative inequalities in cancer screening and early detection and follow-up within the EU, particularly with regard to the diagnostic procedures used and the integration of those procedures into Member States" health policy, and whereas screening programmes facilitate early diagnosis, which contributes to a cost-effective and measurable reduction in disease burden,
ker se onkologija v vseh državah članicah ne priznava kot zdravniška specializacija in ker je treba zagotavljati nenehno zdravstveno izobraževanje,
whereas oncology is not recognised as a medical speciality in all Member States, and whereas continuing medical education needs to be provided,
ker evropska podatkovna baza za klinične študije Evropske agencije za zdravila (EudraCT) ni javno dostopna in pacienti težko najdejo klinične študije, ki zadevajo njihovo zdravstveno stanje,
whereas EudraCT, the European database for clinical trials at the European Medicines Agency (EMEA), is not open to the general public, and patients have difficulty in locating trials that address their specific condition,
poziva Komisijo, naj oblikuje medinstitucionalno delovno skupino EU za boj proti raku, ki bi jo sestavljali predstavniki Komisije, Sveta in Evropskega parlamenta, ki bi se redno srečevali ter zbirali in izmenjevali zglede najboljše prakse za preprečevanje (vključno z zmanjševanjem poklicne in okoljske izpostavljenosti rakotvornim in drugim snovem, ki prispevajo k nastanku raka), preventivne preglede in zdravljenje ter zagotavljali vodenje pri boljšem nadzoru nad rakom v Evropi; poudarja, da bi morala delovna skupina EU še zlasti spodbujati nove ukrepe, pa tudi obstoječe projekte za preventivne preglede, ki bi lahko pripomogli k povečanju deleža prebivalstva, ki sodeluje pri ukrepih preventivnih pregledov za rakava obolenja, za vsaj 50 % v vsaki državi članici do leta 2018;
Calls on the Commission to set up an inter-institutional EU Cancer Task Force composed of Members from the Commission, the Council and the European Parliament which shall meet on a regular basis, to collect and exchange best practice for prevention, (including reducing occupational and environmental exposure to carcinogens and other substances contributing to the development of cancer), screening and treatment and to provide leadership for improved cancer control in Europe; stresses that the EU Task Force should, in particular, promote new measures as well as existing screening projects that can help increase the proportion of the population taking part in cancer screening measures by at least 50% in each of the Member States by 2018;
pozdravlja pobudo Komisije za sprejetje sporočila o raku in sporočila o redkih boleznih, ki sta predvideni za to leto;
Welcomes the Commission's initiative of adopting a Communication on cancer and a Communication on rare diseases, both scheduled for later this year;
poziva Komisijo, naj redno pregleduje evropski kodeks proti raku in ga promovira v kampanjah za osveščanje, obveščanje in izobraževanje, namenjenih točno določenim skupinam prebivalstva;
Asks the Commission to review the European Code Against Cancer on a regular basis and to promote it by means of awareness, information and education campaigns targeting specific population groups;
poziva Komisijo, naj revidira sedanje priporočilo o preventivnih pregledih za rakava obolenja, da bo upoštevalo hiter razvoj novih tehnologij in zajelo:
Calls on the Commission to revise the existing Recommendation on cancer screening to take account of the rapid development of new technologies and to include:
več vrst rakavih obolenj in
more types of cancers; and
dodatne tehnike zgodnjega odkrivanja, ko so te znanstveno preverjene;
additional techniques of early diagnosis when these are warranted scientifically;
poziva Komisijo, naj oblikuje dinamičen, prožen in stalen pristop za boj proti raku, ki bo temeljil na znanstvenem napredku, ter v ta namen ustanovi:
Calls on the Commission to establish a dynamic, flexible and continuous approach to fighting cancer that is based on scientific progress, and to this end to establish:
svetovalni odbor za preprečevanje raka, ki bo ocenil sedanje dokaze in podatke;
an advisory committee on cancer prevention to evaluate existing evidence and data;
poseben svetovalni odbor za zgodnje odkrivanje raka, da zagotovi hitro in učinkovito vključevanje prihodnjih revizij priporočila;
a special advisory committee on early detection of cancer to ensure that future revisions of the recommendation are incorporated rapidly and efficiently;
poziva Komisijo, naj v okviru drugega akcijskega programa za javno zdravje podpre omrežja nacionalnih registrov za primere raka, da bi se izvedla študija za celo EU o razlikah v pojavljanju in preživetju rakavih obolenj;
Calls on the Commission to support, within the framework of the Second Public Health Action Programme, networks of national cancer registries with a view to carrying out an EU-wide study of inequalities in cancer incidence and survival;
poziva vladi Češke in Italije, ki še nista ratificirali Okvirne konvencije SZO o nadzoru tobaka, ki je začela veljati februarja 2005, naj to storita;
Urges the Governments of the Czech Republic and Italy, which have not yet done so, to ratify the WHO Framework Convention on Tobacco Control, which entered into force in February 2005;
poziva Komisijo in vse države članice, naj pri izvajanju Okvirne konvencije SZO o nadzoru nad tobakom razvijejo in podpirajo trdne protokole in smernice ter zagotovijo, da bodo na voljo sredstva, ki bodo državam z nizkimi dohodki pomagala pri izpolnjevanju njihovih obveznosti v skladu s to konvencijo;
Calls on the Commission and all Member States to develop and support strong protocols and guidelines when implementing the WHO Framework Convention on Tobacco Control and to ensure that resources are available to help low-income countries to meet their obligations under the Convention;
poziva Komisijo, naj kot varuhinja Pogodbe takoj sprejme pravne ukrepe proti vsem državam članicam, ki ne izvajajo v celoti Direktive 2004/37/ES;
Calls on the Commission to act in its role as guardian of the Treaty by taking swift legal action against all Member States that are not fully implementing Directive 2004/37/EC;
poziva Komisijo, naj po potrebi sprejme zakonodajo ter spodbuja in podpira pobude, ki vključujejo širok spekter zainteresiranih strani, da bi preprečevali rakava obolenja z zmanjšanjem poklicne in okoljske izpostavljenosti rakotvornim in drugim snovem, ki prispevajo k nastanku raka, ter s spodbujanjem zdravega načina življenja – zlasti kar zadeva glavne dejavnike tveganja, kot so tobak, alkohol, prekomerna telesna teža, nezdravi načini prehranjevanja ter pomanjkanje telesne aktivnosti in slaba zaščita pred soncem – in z močnim poudarkom na otrocih in najstnikih;
Calls on the Commission to take legislative action, where appropriate, and to encourage and support initiatives that include a wide range of stakeholders with the aim to prevent cancer through reduction of occupational and environmental exposure to carcinogens and other substances contributing to the development of cancer and promotion of healthy lifestyles, in particular as regards the major risk factors, tobacco, alcohol, obesity, unhealthy diets, lack of physical activity and sun protection, putting a strong emphasis on children and adolescents;
poziva Komisijo in države članice, naj podpirajo in izvajajo celostne ukrepe za nadzor nad tobakom, vključno z uvajanjem okolij brez cigaretnega dima in pomoči pri opuščanju kajenja, ki sta učinkovita načina zmanjševanja kajenja, ter tako preprečijo veliko število smrti zaradi raka v skladu s svojo resolucijo z dne 24. oktobra 2007 o zeleni knjigi z naslovom "K Evropi brez tobačnega dima: politične možnosti na ravni EU" Sprejeta besedila, P6_TA(2007)0471 .
Calls on the Commission and the Member States to support and implement comprehensive tobacco control policies including smoke free environments and smoking cessation interventions, as effective methods to reduce the incidence of smoking and thus prevent a large number of cancer deaths, in line with its resolution of 24 October 2007 on the Green Paper "Towards a Europe free from tobacco smoke: policy options at EU level" Texts Adopted, P6_TA(2007)0471 .
, katere priporočila je treba zdaj v celoti izvajati;
, the recommendations in which must now be fully implemented;
poziva Komisijo, države članice in Evropsko agencijo za kemikalije, naj v okviru Uredbe (ES) št. 1907/2006 Evropskega Parlamenta in Sveta z dne 18. decembra 2006 o registraciji, evalvaciji, avtorizaciji in omejevanju kemikalij (REACH), o ustanovitvi Evropske agencije za kemikalije UL L 396, 30.12.2006, str.
Calls on the Commission, the Member States and the European Chemicals Agency, in the context of Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) and establishing a European Chemicals Agency OJ L 396, 30.12.2006, p.
Popravek v UL L 136, 29.5.2007, str.
Corrected version in OJ L 136, 29.5.2007, p.
Uredba, kako je bila spremenjena z Uredbo Sveta (ES) št. 1354/2007 (UL L 304, 22.11.2007, str.
Regulation as amended by Council Regulation (EC) No 1354/2007 (OJ L 304, 22.11.2007, p.
kot osrednjo prednostno nalogo do 1. junija 2008 sprejmejo seznam snovi, ki zbujajo veliko zaskrbljenost, vključno z rakotvornimi snovmi, kar bo omogočilo izvajanje člena 33(2) REACH, na podlagi katerega lahko potrošniki zahtevajo informacije o rakotvornih snoveh v potrošniških izdelkih, da se jim lahko izognejo, če to želijo;
, to adopt the candidate list of substances of very high concern, which includes substances that are carcinogenic, as a top priority before 1 June 2008, so as to make possible the application of Article 33(2) of REACH, which allows consumers to request information about carcinogens in consumer items, enabling them to avoid such items if they so desire;
poziva Komisijo, naj spodbuja in podpira pobude za preprečevanje uvoza izdelkov, ki vsebujejo rakotvorne kemikalije; poleg tega poziva k sprejetju EU ukrepov za okrepitev nadzora hrane glede vsebnosti kemikalij, tudi pesticidov;
Calls on the Commission to encourage and support initiatives to prevent the importing of items containing carcinogenic chemicals; calls, furthermore, for EU measures to strengthen food monitoring for chemicals, including pesticides;
poziva Komisijo in države članice, naj zagotovijo, da bodo imele raziskave z biološkim spremljanjem ljudi po vsej EU dovolj sredstev za nadzor rakotvornih in drugih snovi, ki prispevajo k nastanku raka, in tako omogočijo ugotavljanje učinkovitosti politike;
Calls on the Commission and Member States to ensure that EU wide human bio-monitoring surveys are adequately resourced to monitor carcinogenic substances and other substances contributing to the development of cancer, in order to be able to measure policy effectiveness;
poziva Komisijo in države članice, naj spodbujajo informacijske kampanje o preventivnih pregledih za odkrivanje rakavih obolenj, namenjene širši javnosti in vsem ponudnikom zdravstvenih storitev, pa tudi izmenjave najboljše prakse o uporabi ukrepov za preprečevanje ali zgodnje odkrivanje, kot so stroškovno učinkovito vključevanje ustreznega testiranja za humani papiloma virus (HPV) za zgodnje odkrivanje raka na materničnem vratu in cepljenje proti temu virusu za zaščito mladih žensk proti obliki raka, ki jo povzroča, ali preiskave prostatičnega specifičnega antigena (PSA) za zgodnje odkrivanje raka prostate pri moških, starejših od 50 let;
Urges the Commission and the Member States to promote information campaigns on cancer screening directed at the general public and all healthcare providers, as well as exchange of best practice on the use of preventive or early-detection measures, such as cost-effective integration of appropriate human papilloma virus (HPV) testing for cervical cancer screening and HPV vaccination to protect young women from cervical cancer, or the prostate specific antigen (PSA) test for the early detection of prostate cancer in men over 50 years of age;
poziva Komisijo, naj začne razpravo s Svetom, da zagotovi spodbujanje in učinkovito izvajanje priporočila o preventivnih pregledih za rakava obolenja; zato poziva države članice, naj začnejo izvajati to priporočilo, če tega še niso storile, ter oblikujejo postopke za sprejetje morebitnih prihodnjih sprememb priporočila in določijo programe preventivnih pregledov, utemeljenih na prebivalstvu, v skladu z evropskimi smernicami za zagotavljanje kakovosti;
Calls on the Commission to initiate a discussion with the Council to ensure that the Recommendation on cancer screening is promoted and implemented effectively; to this end, urges those Member States that have not yet done so to implement the Recommendation, to establish procedures for the adoption of any future changes to the Recommendation and to set up population-based screening programmes in accordance with European quality-assurance guidelines;
poziva Komisijo, naj zagotovi srednje- in dolgoročno znanstveno in strokovno podporo za ustrezno in primerno pomoč državam članicam, s katero jim bo pomagala pri izvajanju priporočila Sveta o preventivnih pregledih za raka, ter spremlja, ocenjuje in usklajuje poskusne dejavnosti in stalno izboljševanje kakovosti;
Calls on the Commission to guarantee medium- and long-term scientific and professional support for adequate and appropriate assistance to the Member States to help them act on the Council Recommendation on cancer screening and monitor, evaluate and coordinate pilot activities and continuous quality improvement;
poziva Komisijo, naj podpira razvoj evropskih programov za akreditacijo/certificiranje na področju preventivnih pregledov za odkrivanje, diagnosticiranje in zdravljenje raka, ki bodo temeljili na evropskih smernicah za zagotavljanje kakovosti, kar bi lahko bilo zgled drugim področjem zdravstvene oskrbe;
Calls on the Commission to support the development of European accreditation/certification programmes in cancer screening, diagnosis and treatment based on European quality-assurance guidelines, which could also serve as an example for other areas of health care;
poziva države članice, naj zagotovijo multidisciplinarne onkološke skupine za celotno opdročje države, da bodo vsi bolniki dobili najboljše možno zdravljenje, in naj izboljšajo usposabljanje onkologov in zdravstvenih strokovnjakov na področju prepoznavanja psihosocialnih potreb obolelih za rakom, da bi se izboljšala njihova kakovost življenja ter zmanjšala njihov strah in depresija;
Calls on the Member States to make nationwide provision for multidisciplinary oncology teams to give optimal individual treatment to all patients, and to improve training of oncologists and healthcare professionals in recognising the psychosocial needs of patients in order to improve their quality of life and reduce anxiety and depression in cancer patients;
poziva Komisijo, naj nameni sredstva iz strukturnih skladov in Sedmega okvirnega programa za raziskave za oblikovanje in financiranje referenčnih omrežij za redka in težko ozdravljiva rakava obolenja, da bi se zbrala sredstva ter znanje in izkušnje in izboljšali diagnostika in zdravljenje;
Calls on the Commission to deploy funds from the Structural Funds and the Seventh Framework Programme for Research to create and fund reference networks for rare and difficult-to-treat cancers, in order to pool resources and expertise and improve diagnosis and treatment;
poziva Komisijo, naj v okviru Sedmega okvirnega programa dodeli sredstva za spodbujanje raziskav in inovacij na področju osnovne preventive, preventivnih pregledov in zgodnjega odkrivanja raka ter novih zdravil in oblik zdravljenja raka;
Urges the Commission to allocate funds within the Seventh Framework Programme in order to encourage research and innovation in the areas of primary prevention, screening and early detection, and new anti-cancer medicines and treatments;
poziva Komisijo, naj v okviru Sedmega okvirnega programa dodeli sredstva za spodbujanje raziskav o raku pri otrocih;
Calls on the Commission to allocate funds under the Seventh Framework Programme to stimulate research on paediatric cancers;
poziva Komisijo in države članice, naj zagotovijo, da bodo zdravila za rakava obolenja v vseh državah članicah enako dostopna vsem pacientom, ki jih potrebujejo;
Urges the Commission and Member States to ensure that cancer medicines are uniformly available to all patients who need them in all Member States;
spodbuja Komisijo in države članice, naj v okviru farmacevtskega foruma na visoki ravni preučijo, kako bi lahko bolnikom hitreje zagotovili dostop do inovativnih zdravil proti raku, ki rešujejo življenja, in sicer s pospeševanjem hitrega izdajanja dovoljenj za trženje prek centraliziranega postopka na ravni EU, ter naj preučijo možnost postopka pogojevanja cen in povračil, kadar se podatki o vrednosti zdravila zbirajo pri bolnikih v njihovem življenjskem okolju;
Encourages the Commission and Member States to examine within the high-level Pharmaceutical Forum how innovative life-saving cancer medicines can be made available more speedily to patients by accelerating fast-track marketing approval through the EU Centralised Procedure and to consider a conditional pricing and reimbursement process, while data on the value of the medicine is collected on patients in real-life settings;
poziva Komisijo, naj najpozneje do junija 2008 Evropskemu parlamentu in Svetu predstavi predlog za zagotavljanje visokokakovostnih, objektivnih, zanesljivih in nepropagandnih informacij o zdravstvenih izdelkih iz različnih virov;
Calls on the Commission to submit a proposal to the European Parliament and the Council by June 2008 at the latest to provide for good-quality, objective, reliable, non-promotional information on medicinal products from multiple sources;
poziva Komisijo, naj revidira Direktivo 2001/20/ES Evropskega parlamenta in Sveta z dne 4. aprila 2001 o približevanju zakonov in drugih predpisov držav članic v zvezi z izvajanjem dobre klinične prakse pri kliničnem preskušanju zdravil za ljudi UL L 121, 1.5.2001, str.
Calls on the Commission to revise Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001 on the approximation of the laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use OJ L 121, 1.5.2001, p.
(Direktivo o kliničnem preizkušanju), da bi spodbudila več akademskih raziskav na področju raka, še zlasti raziskave o preventivnih pregledih in zgodnjem odkrivanju rakavih obolenj, pri čemer naj upošteva stroške, povezane z neprofitnim raziskovalnim sektorjem, ter naj izboljša razpoložljivost informacij o kliničnih študijah, ki so v teku ali so že zaključeni, za bolnike in občo javnost;
(the Clinical Trials Directive) to encourage more academic research on cancer, and in particular research into cancer screening and early detection, whilst recognising the impact of the costs involved for the non-commercial research sector, and to improve the availability of information for patients and the general public on ongoing and completed clinical trials;
poziva države članice in Komisijo, naj si prizadevajo za razvoj smernic za skupno opredelitev invalidnosti, ki po možnosti vključuje ljudi s kroničnimi boleznimi in rakom, in hkrati poziva države članice, ki tega še niso storile, naj te ljudi po možnosti vključijo v opredelitve invalidnosti, kakršne veljajo v njihovi državi;
Calls on the Member States and the Commission to work towards the development of guidelines for a common definition of disability that may include people with chronic illnesses or cancer and in the meantime for Member States, who have not done so, to act quickly possibly to include those people within their national definitions of disability;
poziva Komisijo, naj pripravi listino o zaščiti obolelih za rakom in kroničnih bolnikov na delovnem mestu, da bi se lahko od podjetij zahtevalo, naj obolelim omogočijo nadaljevanje delovnega razmerja med zdravljenjem in vrnitev k njihovim običajnim poklicnim dejavnostim;
Calls on the Commission to draw up a charter for the protection of cancer patients and chronically sick people in the workplace with a view to requiring companies to enable patients to continue in employment during their treatment and to return to their normal professional activities;
spodbuja države članice, naj v skladu z evropskimi smernicami sprejmejo nacionalne listine o pravicah bolnikov in naj v oblikovanje zdravstvene politike vključijo soudeležbo in strokovno znanje bolnikov;
Encourages the Member States to adopt national Charters of patients" rights in accordance with European guidelines and to include patient participation and expertise in the development of health policies;
poziva države članice in Komisijo, naj razvijejo in okrepijo pobude, ki zagotavljajo podporo ljudem, ki jih je rak neposredno ali posredno prizadel, zlasti z uvedbo in razvojem psihološke oskrbe in podpore za preživele rakave bolnike po vsej Uniji;
Calls on the Members States and the Commission to develop and strengthen initiatives that provide support for people directly or indirectly affected by cancer, in particular through the initiation and development of psychological care and support throughout the EU for cancer survivors;
poziva Komisijo, naj obolelim za rakom zagotovi več informacij, in sicer s spodbujanjem pobud, ki bolnike obveščajo o možnostih zdravljenja in dostopu do njih, in poziva vsa prihodnja predsedstva, naj rakava obolenja še naprej postavljajo za prednostno nalogo;
Calls on the Commission to increase the information available to cancer patients by encouraging initiatives which inform patients about their treatment options and ways to access such treatments;
spodbuja nove države članice, naj v večji meri uporabljajo strukturne sklade za izboljšanje zdravstvene infrastrukture, na primer s podporo izvajanju priporočila Sveta o preventivnih pregledih za raka;
Encourages new Member States to make greater use of the Structural Funds to improve healthcare infrastructure, for example by supporting implementation of the Council Recommendation on cancer screening;
podpira slovensko predsedstvo EU, ki je rakava obolenja postavilo za eno od svojih prednostnih nalog v letu 2008;
Supports the Slovenian EU Presidency, which has made cancer one of its priorities in 2008, and calls on all future presidencies to continue to make cancer a priority;
Resolucija Evropskega parlamenta z dne 10. aprila 2008 o vmesnem pregledu šestega okoljskega akcijskega programa Skupnosti ( 2007/2204(INI) )
European Parliament resolution of the 10 April 2008 on the mid-term review of the Sixth Community Environment Action Programme ( 2007/2204(INI) )
ob upoštevanju svoje resolucije z dne 14. novembra 2006 o tematski strategiji za varstvo in ohranjanje morskega okolja UL C 314 E, 21.12.2006, str.
having regard to its resolution of 14 November 2006 on a Thematic Strategy on the Protection and Conservation of the Marine Environment OJ C 314 E, 21.12.2006, p.
ob upoštevanju svojega stališča iz prve obravnave 14. novembra 2006 o predlogu Direktive Evropskega parlamenta in Sveta o določitvi okvira za ukrepe Skupnosti na področju politike morskega okolja (Direktiva o morski strategiji) UL C 314 E, 21.12.2006, str.
having regard to its position at first reading of 14 November 2006 on the proposal for a directive of the European Parliament and of the Council establishing a Framework for Community Action in the field of Marine Environmental Policy (Marine Strategy Directive) OJ C 314 E, 21.12.2006, p.